A Multicenter Retrospective Study on Real-World Outcomes of ceftazidime-avibactam in gram-negative bacterial infection in Taiwan

Ceftazidime-avibactam (CAZ-AVI) has been launched in Asian countries for five years, local real-world data about infections, patient characteristics, efficacy, and safety of CAZ-AVI in gram-negative bacterial infection is limited. We conducted a multicenter, retrospective cohort study to investigate...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Tsung Ying Zegma Yang, Yee Chun Chen, Yi Tsung Lin, Ching Tai Huang, Po Yu Liu, Po Liang Lu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2024-12-01
Serie:	Journal of Global Antimicrobial Resistance
Soggetti:	ceftazidime-avibactam real-world experience multidrug-resistant gram-negative bacterial infections
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2213716524001838
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!